| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/28/2000 | CA2375798A1 Capillary electrophoresis method for screening for affinity ligands using a detectable competitive ligand |
| 12/28/2000 | CA2375781A1 Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abci |
| 12/28/2000 | CA2375771A1 Nucleic and proteinic acids corresponding to human gen abc1 |
| 12/28/2000 | CA2375550A1 Methods and device for in vitro detection and characterization of psychoactives using analysis of repetitive electrical activity in a neuronal sample |
| 12/28/2000 | CA2375542A1 Compositions and methods for assaying subcellular conditions and processes energy transfer |
| 12/28/2000 | CA2375532A1 Dehydration/rehydration of marked liposomes on a test device |
| 12/28/2000 | CA2375527A1 Method for enhancing hematopoiesis |
| 12/28/2000 | CA2375516A1 Multiple sensing system and device |
| 12/28/2000 | CA2375508A1 Methods and products for manipulating uncoupling protein expression |
| 12/28/2000 | CA2375498A1 Epithelial cell growth inhibitors |
| 12/28/2000 | CA2375493A1 Human transport proteins |
| 12/28/2000 | CA2375484A1 In vivo insect model system for type-2 diabetes |
| 12/28/2000 | CA2375480A1 Head trauma induced cytoplasmatic calcium binding protein |
| 12/28/2000 | CA2375477A1 Novel calpains and their use |
| 12/28/2000 | CA2375414A1 Human transcriptional regulator proteins |
| 12/28/2000 | CA2375407A1 Rna metabolism proteins |
| 12/28/2000 | CA2375207A1 Peptide having preptin functionality |
| 12/28/2000 | CA2368099A1 Adenosine diphosphatase and activators thereof and their medical uses |
| 12/27/2000 | EP1063527A2 Automated analyser and automated analysis |
| 12/27/2000 | EP1063526A2 Procedure for the analysis of the functional activation of leukocytes, platelets and other cells |
| 12/27/2000 | EP1063525A2 Method for measuring the quantity of heat present in fuel gas |
| 12/27/2000 | EP1063524A2 Apparatus for analyzing a volatile composition of matter releasably bonded to a pliable porous substrate and process for using said apparatus. |
| 12/27/2000 | EP1063522A2 Ultrasonic seafood probe |
| 12/27/2000 | EP1063521A1 Device for testing ferromagnetic tubes |
| 12/27/2000 | EP1063517A1 Apparatus for measuring the interaction between surfaces and rubber specimens |
| 12/27/2000 | EP1063511A2 Device for analyzing organic compounds, particularly in aqueous and gaseous samples |
| 12/27/2000 | EP1063510A1 Analysis system for the atmosphere of a hard-soldering or tin-plating cavity |
| 12/27/2000 | EP1063509A2 Sampling devices |
| 12/27/2000 | EP1063508A1 Container for urine test |
| 12/27/2000 | EP1063298A2 Transgenic Animal Model for Alzheimer Disease |
| 12/27/2000 | EP1063293A2 Transforming growth factor alpha H1 |
| 12/27/2000 | EP1063292A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 12/27/2000 | EP1063291A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 12/27/2000 | EP1063286A1 Substrates for immobilizing and amplifying dna, dna-immobilized chips having dna immobilized on the substrates, and method for amplifying dna |
| 12/27/2000 | EP1062909A2 Filter unit for end tidal carbon monoxide concentration apparatus and method |
| 12/27/2000 | EP1062840A1 Apparatus and method for a custom soft-solid hearing aid |
| 12/27/2000 | EP1062517A2 Diagnosis of spongiform encephalopathies using prionins |
| 12/27/2000 | EP1062516A1 Detection of analytes by fluorescent lanthanide chelates |
| 12/27/2000 | EP1062515A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
| 12/27/2000 | EP1062514A2 C-myc coding region determinant-binding protein (crd-bp) |
| 12/27/2000 | EP1062513A1 Method for detecting microbes from an enrichment culture |
| 12/27/2000 | EP1062512A1 Methods and tools for identifying compounds which modulate atherosclerosis by impacting ldl-proteoglycan binding |
| 12/27/2000 | EP1062511A1 Immunoassays involving surface enhanced raman scattering |
| 12/27/2000 | EP1062510A2 Integrated assay device and methods of production and use |
| 12/27/2000 | EP1062509A2 Methods and compositions for diagnosis of rheumatoid arthritis |
| 12/27/2000 | EP1062508A1 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof |
| 12/27/2000 | EP1062507A1 Determination of white blood cell differential and reticulocyte counts |
| 12/27/2000 | EP1062506A2 Method of, and device and system for, monitoring soil moisture content |
| 12/27/2000 | EP1062502A1 Microfabricated capillary electrophoresis chip and method for simultaneously detecting multiple redox labels |
| 12/27/2000 | EP1062495A1 Calibration of a whole blood sample analyser |
| 12/27/2000 | EP1062366A1 Detection of neoplasia by analysis of saliva |
| 12/27/2000 | EP1062344A2 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 12/27/2000 | EP1062342A1 Genetic sequences conferring pathogen resistance in plants and uses therefor |
| 12/27/2000 | EP1062340A2 Compositions and methods for the treatment and prevention of metastatic disorders |
| 12/27/2000 | EP1062339A2 Human fgf gene and gene expression products |
| 12/27/2000 | EP1062338A2 Human membrane spanning proteins |
| 12/27/2000 | EP1062334A1 Mammalian sodium channel proteins |
| 12/27/2000 | EP1062333A1 Chondrosarcoma associated genes |
| 12/27/2000 | EP1062331A1 Compounds related to pap-1 |
| 12/27/2000 | EP1062323A2 Methods of diagnosis and triage using cell activation measures |
| 12/27/2000 | EP1062246A1 Anti-inositolphosphoglycan monoclonal antibodies |
| 12/27/2000 | EP1062241A1 Fas-associated polypeptides |
| 12/27/2000 | EP1062239A2 Ribonucleotide polypeptides containing metal |
| 12/27/2000 | EP1062238A1 Ecr673: a 7-transmembrane g-protein coupled receptor |
| 12/27/2000 | EP1062222A1 Serine peptidase modulators |
| 12/27/2000 | EP1062044A2 Detection and characterization of microorganisms |
| 12/27/2000 | EP1062033A1 Apparatus and method for combinatorial research for catalysts and polymers |
| 12/27/2000 | EP1061800A1 Compositions and methods for modulating vascularization |
| 12/27/2000 | EP0937158B1 METHOD FOR DETERMINING THE CATALYTIC ACTIVITY OF FACTOR IXa |
| 12/27/2000 | EP0859951A4 Selective gas sensor |
| 12/27/2000 | EP0843816B1 Determination of an analyte in a liquid medium |
| 12/27/2000 | EP0830607A4 Selection of livestock using igf levels |
| 12/27/2000 | EP0804483B1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
| 12/27/2000 | EP0789843A4 Apparatus for pumping and directing fluids for hematology testing |
| 12/27/2000 | CN1278330A fiber quality monitor |
| 12/27/2000 | CN1278301A Procine circoviruses, vaccines and diagnostic reagents |
| 12/27/2000 | CN1278300A Multivalent antigen-binding proteins |
| 12/27/2000 | CN1278065A Method for investigating alpha-fetoprotein heteroplasmon |
| 12/27/2000 | CN1278062A Luminosity type surface plasmon resonation biological sensor |
| 12/27/2000 | CN1277970A Novel polypeptide-human sarcoma protein 20, and polynucleotide for coding same |
| 12/27/2000 | CN1059928C Method for preparing antigenic protein capable of testing C-type hepatitis by using colibacillus |
| 12/26/2000 | USRE37002 Lipid-dispersed solution, production thereof and use in determining lipid levels |
| 12/26/2000 | US6167362 Motivational tool for adherence to medical regimen |
| 12/26/2000 | US6166807 Method of urinalysis, urinalysis apparatus, method of measuring angle of rotation and polarimeter |
| 12/26/2000 | US6166546 Method for determining the relative clay content of well core |
| 12/26/2000 | US6166385 Multi-photon laser microscopy |
| 12/26/2000 | US6166382 Method for determining feed quality |
| 12/26/2000 | US6166251 Labeled reagents for use in immunoassays and fluorescent compounds and complexes used therein |
| 12/26/2000 | US6166202 Benzophenoxazine dyes |
| 12/26/2000 | US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy |
| 12/26/2000 | US6166192 PGC-1, a novel brown fat PPARγ coactivator |
| 12/26/2000 | US6166187 Method of concentrating prion proteins in blood samples |
| 12/26/2000 | US6166185 Antibodies to human TIE-2 ligands |
| 12/26/2000 | US6166182 Polypeptides for the treatment of bacterial, fungal, protozoan and viral infections |
| 12/26/2000 | US6166180 Polypeptide for the treatment of genetic disorders associated with transmembrane protein |
| 12/26/2000 | US6166178 Polypeptide for the treatment of cancer; anticarcinogenic agents |
| 12/26/2000 | US6166090 Prevention atherosclerosis; administering transforming growth factor |
| 12/26/2000 | US6166049 A treatment and/or prophylaxis of hyperglycaemia, pre-diabetic insulin resistance syndrome by administering an agonist of peroxisome proliferator-activated receptor to stimulate fatty oxidation |
| 12/26/2000 | US6165992 Histidine kinase |
| 12/26/2000 | US6165991 A polynucleotide, or the full complement of the entire length of the polynucleotide, which encodes the same mature polypeptide, expressed by histidine kinase encoded by a specific polynucleotide contained in streptococcus pneumoniae |